Apogee Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Apogee Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Apogee Therapeutics Inc.
Rating: 1.53850
Author: Trendlyne DVM scores

about

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment ...

83.91 -0.03 (-0.04%)

144.35% Gain from 52W Low

607.0K

XNAS Volume

XNAS 14 May, 2026 4:00 PM (EDT)

Not Eligible

Expensive Valuation

0.0 / 100

Technically Moderately Bullish

61.5 / 100

No estimates available

Apogee Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Apogee Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment ...

144.35% Gain from 52W Low

SWOT Analysis

Apogee Therapeutics Inc Live Price Chart